Stay updated with breaking news from Specifict Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A heterologous fourth dose (second booster) with either aerosolised Ad5-nCoV or intramuscular Ad5-nCoV was safe and highly immunogenic in healthy adults who had been immunised with three doses of CoronaVac.
/PRNewswire/ -- IsoPlexis (NASDAQ: ISO), the leader in functional single cell proteomics, today announced that new data generated on its IsoLight® platform...
Share this article Share this article HOUSTON, Jan. 13, 2021 /PRNewswire/ -- Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that it has completed the construction and qualification of its cGMP manufacturing facility in Houston, TX, located near the George Bush Intercontinental Airport. The facility will allow production of MultiTAA-specific T cell products according to U.S. Food and Dru...